#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3301363	Physicochemical	ASTRAZENECA: Octan-1-ol/water (pH7.4) distribution coefficent measured by a shake flask method described in J. Biomol. Screen. 2011, 16, 348-355. Experimental range -1.5 to 4.5		4,197	ALA3301361	small-molecule physicochemical format	AstraZeneca Deposited Data
2.	ALA3301366	ADME	ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma at 37C for >5hrs. Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.	Rattus norvegicus	717	ALA3301361	cell-free format	AstraZeneca Deposited Data
3.	ALA3301367	ADME	ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma at 37C for >5hrs. Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.	Canis lupus familiaris	244	ALA3301361	cell-free format	AstraZeneca Deposited Data
4.	ALA3301369	ADME	ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole guinea pig plasma at 37C for >5hrs. Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.	Cavia porcellus	91	ALA3301361	cell-free format	AstraZeneca Deposited Data
5.	ALA3301372	ADME	ASTRAZENECA: Intrinsic clearance measured in human hepatocytes following incubation at 37C. Experimental range <3 to >150 microL/min/1E6 cells. Rapid Commun. Mass Spectrom. 2010, 24, 1730-1736.	Homo sapiens	408	ALA3301361	cell-based format	AstraZeneca Deposited Data
6.	ALA4303805	Functional	Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging	Homo sapiens	5,612	ALA4303101	organism-based format	SARS-CoV-2 Screening Data 2020-21
7.	ALA4495582	Functional	SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate	Severe acute respiratory syndrome coronavirus 2	7,212	ALA4495564	assay format	SARS-CoV-2 Screening Data 2020-21
8.	ALA4513082	Functional	Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging	Chlorocebus sabaeus	7,212	ALA4495565	organism-based format	SARS-CoV-2 Screening Data 2020-21
9.	ALA4808149	Binding	Enzymatic assay of human HDAC6 with commercial peptide substrate	Homo sapiens	5,603	ALA4808148	single protein format	Fraunhofer HDAC6
10.	ALA4808150	Binding	Enzymatic assay of human HDAC6 with custom peptide substrate	Homo sapiens	5,603	ALA4808148	single protein format	Fraunhofer HDAC6